🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 New Preprint Alert! 🚨 I’m thrilled to share our latest study now online on JCI: CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer. 🔬 Check out the preprint here: doi.org/10.1172/JCI179… Huge thanks to

Proud of our LIG1 loss/PARP inhibition #SL study in Journal of Clinical Investigation by Giulia Fracassi an Fondazione AIRC per la ricerca sul cancro fellowship awardee and Francesca Lorenzin a PCF Science YIA Collaborators: Joaquin Mateo Fabrizio d'Adda di Fagagna Relevant to #prostatecancer and beyond. Download it! jci.org/articles/view/…

The indiscriminate and ill-conceived slashing of indirects by the NIH yesterday must be amended if want to restore America’s leadership role biomedical research. 15% simply isn’t enough for institutions to provide the basic infrastructure needed to run a successful lab. I say

It's really cool that Tom Brady got to be there for the Eagles' two Super Bowl wins! He might be a good luck charm. Have a great night!

🚨BIG NEWS!!🚨 👉Parwiz Abrahimi MD, PhD will be joining our faculty as a surgeon scientist🔬 ✅He will join us this Fall after completing his Society of Urologic Oncology fellowship Weill Cornell Medicine Urology Jim Hu Chris Barbieri Hyung Kim Stephen Freedland, MD Andrew J. Hung, MD Jeremiah Dallmer MD Cedars-Sinai Eric Lo, MD

New paper from my group and Gilad Evrony’s! nature.com/articles/s4146… Historically we measured new mutations in humans using trio studies (parents and offspring). This taught us that on average new mutations increase in offspring with paternal age. These trio studies showed

National Cancer Institute Grant Funds Prostate Cancer Imaging Study news.weill.cornell.edu/news/2025/05/n… Weill Cornell Medicine Urology WCM GU Cancer

Thrilled to share our latest work published in #NatureCancer! 🥳We uncover the metabolic vulnerability of and develop novel therapy for advanced prostate cancer with SPOP and CHD1 defects! Grateful to my amazing team, collaborators, and supporters! 🙏MD Anderson Cancer Center Read it here:

sciencedirect.com/science/articl…

🎉 Excited to share our new publication in Cell Reports Medicine! 🙌 Big thanks to our amazing collaborators! 📄 lnkd.in/grHHDkKB #LiquidBiopsy #Oncosomes #EVresearch #RNASeq #CancerBiology #CellReportsMedicine

Favorite study! Germline-somatic tandems dictate cancer subtypes, provide clinical insights, and fuel molecularly informed studies. Kudos: Blerta Stringa, @Paola_Gasperini, Alessandro Alaimo, and Lunardi Lab @ CIBIO (co-last a!) Nima Sharifi doi.org/10.1158/2159-8… Università di Trento

Bashir Al Hussein Al Awamlh, MD, MPH, (Bashir Al Hussein) discusses the relatively low utilization of incontinence procedures post-radical prostatectomy. Weill Cornell Medicine Urology #pcsm urologytimes.com/view/post-rp-i…

Many men who survive cancer go on to become fathers; however, the effects of the treatment on sperm was unknown. Shany Picciotto Camilo Arenas-Gallo Jonathan Evan Shoag 🇮🇱🇺🇸 & team discover chemotherapy exposure is associated with an increase in new mutations in sperm of humans and mice:

Check out our AUA sponsored podcast “Physician Scientist - Different Paths to Success (2025)” - many directions, many opportunities for success. Amer. Urol. Assn. Urology Care Foundation Rose Khavari MD Chris Barbieri Dr Neal Shore CURC Dr Peter Schulam Johnson & Johnson youtu.be/1Jnz5SX-MB4